Baxter International Inc
NYSE:BAX
Operating Margin
Baxter International Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Baxter International Inc
NYSE:BAX
|
15.9B USD |
6%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
226.9B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
183.6B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
151.6B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
140.9B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.9B USD |
19%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.4B EUR |
13%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.8B USD |
14%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.9B USD |
28%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
35.5B USD |
29%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
261.7B CNY |
36%
|
Baxter International Inc
Glance View
Baxter International Inc. finds its roots in the early 1930s, a time when the healthcare landscape was vastly different. Founded by Donald Baxter, a medical doctor seeking to improve the quality and safety of intravenous therapy, the company initially focused on researching and developing safe ways to provide patients with sterile intravenous solutions. As the years unfolded, Baxter transformed itself from a small operation into a globally recognized healthcare giant. Today, it operates in the realm of lifesaving medical products and services, specializing in the development of essential pharmaceuticals, clinical nutrition for hospitals, advanced kidney care solutions, and critical care technology that healthcare providers depend on daily. Central to Baxter's business model is its commitment to innovation and improving patient outcomes, which drives its success and profitability. By leveraging its expertise in areas like renal and hospital products, Baxter is able to cultivate a diversified portfolio. This diversification not only helps the company mitigate risks but also strengthens its market position. Revenue streams are generated through the manufacture and sale of medical devices and pharmaceuticals, catering mostly to hospitals, clinics, and renal care centers worldwide. Baxter consistently reinvests in its research and development, aiming to pioneer novel therapies and products that address the evolving needs of the healthcare sector, ensuring that it remains a key player in the ongoing story of medical progress.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Baxter International Inc's most recent financial statements, the company has Operating Margin of 6.5%.
You don't have any saved screeners yet